mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |